17 October 2014 Last updated at 06:33 BST UK pharmaceuticals firm GlaxoSmithKline says its Ebola vaccine will "come too late" for the current epidemic. GSK is one of several companies trying to fast-track a vaccine to prevent the spread of Ebola in West Africa. But Dr Ripley Ballou, head of GSK's Ebola vaccine research, said full data on its safety and efficacy would not...
↧